Clinical Trial Update: Comparing 68Ga-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating cadonilimab plus 68Ga-FAPI PET-guided abdominal radiotherapy versus second-line standard therapy in colorectal cancer with peri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Metastasis

Drugs mentioned

• 68Ga-FAPI (gallium-68 labeled fibroblast activation protein inhibitor)
• Cadonilimab

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer, Peritoneal (Metastatic) Cancer | Phase 2 | Status: RECRUITING